The first report presents an analysis of the drug markets in the European Neighbourhood Policy-South region covering Algeria, Egypt, Israel, Jordan, Lebanon, Libya, Morocco, Palestine, Syria and Tunisia. Focused on providing insights into drug production, trafficking, sale, use and harms, the report contains data and information from a review of publicly available information and selected studies conducted between 2019 and 2022 in the framework of the EU4Monitoring Drugs project, funded by the European Commission. It concludes with an outlook on key areas for policy and practice to address emerging drug market challenges.

The second report presents an analysis of the drug markets in the European Neighbourhood Policy-East region covering Armenia, Azerbaijan, Belarus, Georgia, Moldova and Ukraine. Focused on providing insights into drug production, trafficking, sale, use and harms, the report contains data and information from studies conducted between 2019 and 2022 in the framework of the EU4Monitoring Drugs project, funded by the European Commission. It concludes with an outlook on key areas for policy and practice to address emerging drug markets’ challenges.

See also, Drug-related health and security threats in the Western Balkans.